InvestorsHub Logo
Followers 27
Posts 5261
Boards Moderated 1
Alias Born 08/02/2006

Re: PeterS237 post# 1208

Monday, 03/29/2010 10:49:43 AM

Monday, March 29, 2010 10:49:43 AM

Post# of 8504
more news is due in april... head to head with fluzone. note today's pr and the earnings conference call highlighted that neuraminidase inhibition is a big focus and that the co is in ongoing discussions with the FDA as to how to do a phase III.

flu is flu and pandemic becomes seasonal... next year all the seasonal shots will have AH1N1 in them. i guess this is what nvax is talking to the fda about... how to design a phase III that meets seasonal and pandemic standards.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News